from the director - Georgetown University

from the director 

Over the past year at Lombardi we have 

conducted a rigorous strategic planning 

process and in doing so have reinforced the 

elements that make up our mission: 

n patient care 

n research 

n education 

n community 

These elements have always been at our 

core, but as we move forward, we find con- 

tinued inspiration in the important new 

ways that we can address each of these 

critical areas of Lombardi’s mission. 

These four elements of our mission do not 

exist in a vacuum—they are intimately con- 

nected: 

� Patient care is impacted by our 

research findings, 

� Our education activities are anchored in 

the patient care and research activities, 

� Our community initiatives seek to 

provide education, patient care, and 

venues for research. 

This report highlights some of the exciting 

advances at Lombardi from 2008, within 

each of these four mission elements, as 

well as across them. 

I would like to end by thanking the many 

dedicated friends of Lombardi who make 

possible our advances in the fight against 

cancer. Your support makes an impact 

every single day. 

Louis m. Weiner, md 

Director 

Georgetown Lombardi Comprehensive 

Cancer Center 

1

2 

Lombardi defeats cancer through scientific discovery and 

cutting-edge medicine, guided by the principle of cura personalis— 

care of the whole person. 

patient care �� Lombardi clinicialns are dedicated to providing the best professional care, 

delivered with compassion for all patients. Lombardi’s internationally-renowned physicians treat 

virtually every type of cancer, including breast, lung, colorectal, prostate, head and neck, and 

cancers of the blood. Lombardi patients have access to multi-disciplinary teams of specialists, 

which include oncologists, surgeons, and radiation oncologists. Complementing our state-of-the- 

art cancer care, we offer a program of innovative clinical trials and a full range of supportive care 

services to improve the health and quality of life of our patients and their families 

research �� Lombardi’s world-renowned scientists are discovering cancer risk factors, designing 

effective prevention strategies, and learning how to detect cancers at their earliest stages. Above 

all, they are developing and testing the cancer treatments of tomorrow—targeted therapies that 

will improve both survival and quality of life. Our researchers work in the lab, in the classroom, in 

the clinic, and in the community to help answer the biggest questions in cancer research and we 

are making progress toward the ultimate goal: defeating cancer. 

education �� Lombardi is committed to the education and training of tomorrow’s leaders in 

cancer treatment and research. Our education and training programs span all levels of learning— 

from programs for high school students to postdoctoral fellowships. The Cancer Center offers 

four masters degrees as well as a doctorate in Tumor Biology. Lombardi’s clinical fellowship in 

hematology/oncology is one of the leading programs of its kind. Lombardi educates physicians, 

scientists, and health care professionals committed to the care of others and the health needs of 

society—always integrating educational excellence, ethics and a commitment to community. 

community �� Lombardi is a resource for our community: locally, for residents of Washington, 

DC; regionally, as the only Comprehensive Cancer Center in the greater metropolitan area; and 

nationally and internationally by advancing the standard of cancer care through our research. 

Lombardi is particularly dedicated to serving the population of the Washington, DC area, which 

has some of the highest cancer incidence and death rates in the country. Our goal is to reduce 

disparities and the cancer burden among different ethnic minority groups and underserved populations 

of the District of Columbia.

leading 

by example 

Lombardi’s impact on the field 

of oncology has been driven 

by highly specialized efforts 

to transform cancer research 

and care. In 2008 we launched 

two new initiatives dedicated to 

doing just that: the Georgetown 

Database of Cancer and the 

Health Disparities Initiative. 

3

4 

leading by example 

LefT TO rIGHT: 

claudine isaacs, md 

co-Leader, Breast Program & medical oncologist 

subha madhavan, phd 

Director, Clinical Research Informatics 

louis Weiner, md 

Director, Georgetown Lombardi Comprehensive 

Cancer Center 

robert clarke, phd, dsc 

co-Leader, Breast Cancer Program & basic scientist 

the vision behind G-doc 

One year ago, Louis M. Weiner, MD, was named Director of the 

Georgetown Lombardi Comprehensive Cancer Center. His vision 

included a novel approach to bringing advances in research and 

treatment into practice for the community. Dr. Weiner’s vision has 

manifested itself as the Georgetown Database of Cancer (G-DOC), 

a tool under development that promises to deliver on the founding 

principle of Lombardi and Georgetown University Medical Center, 

cura personalis, or the care of the whole person.

The Georgetown Database 

of Cancer 

the Georgetown database of cancer (G-doc) is a major step toward personalized medicine, an essential concept 

when dealing with the unique nature of cancer. 

dr. Weiner � �The G-DOC is a mechanism to bring all 

data for one patient together, and then compare it to 

the same of data from every other patient with a similar 

disease. By comparing this data, Lombardi researchers 

seek to identify the factors that most reliably track with 

clinical outcomes. The tool is in fact a series of databases, 

combining clinical information from patients with 

a database containing analyses of the molecular characteristics 

of each patient’s cancer. Some have estimated 

that every patient will generate about 1,000,000,000, 

000,000,000,000,000,000,000,000,000,000 

[or 10 39 ] bytes of data for analysis. This includes information 

ranging from molecular data about DNA, proteins, 

and other markers in the cancer cells, imaging scans, 

and treatment information. 

“ Georgetown and its Lombardi comprehensive cancer 

center are committed to reducing the burden of cancer 

through the discovery and early adoption of cuttingedge 

systems biology based tools.” 

dr. madhavan �� Subha Madhavan, MS, PhD, was 

named Lombardi’s first Director of Clinical research 

Informatics in October of 2008. She was recruited to 

Lombardi from the National Cancer Institute to coordin- 

ate combining the existing databases into the new in- 

frastructure. G-DOC will take advantage of standards 

and best practices from other large-scale informatics 

projects to help integrate the wide variety of patient data 

it will hold. 

“ although we are still in the early stages, my hope 

is that implementation of G-doc will increase the 

amount of useful information available to physicians, 

allowing them to tailor treatments more specifically 

and accurately.” 

dr. cLarke �� robert Clarke, PhD, DSc, is a basic sci- 

entist whose research focuses on correlating gene ex- 

pression with clinical characteristics of cancer in order 

to identify options for more personalized treatments. 

G-DOC’s collection of patient disease and treatment 

information will allow researchers like Dr. Clarke to 

make connections between outcomes and the clinical 

and molecular characteristics of cancer. In the process, 

he and other scientists will discover new ways to more 

effectively attack cancer cells, creating many targets for 

new cancer drugs. 

“ there are millions of proteins in the body, and we can 

measure if one is switched on and another off. but the 

problem is that we can’t tell which one is important 

for an individual patient’s cancer. G-doc represents 

a major step forward in addressing this dilemma.” 

dr. isaacs �� Claudine Isaacs, MD, is the director of 

Lombardi’s familial Cancer registry, which tracks one of 

the nation’s largest collections of individuals from high- 

risk breast cancer families. The registry will become an 

anchor in the larger G-DOC—and will be one of the first 

existing databases to be incorporated into the new infrastructure. 

The pilot projects in preparation for 2009 will 

study how the 10 39 bytes of patient information can be 

most effectively presented to the doctors and nurses who 

provide care to Lombardi’s patients. Some estimates 

suggest that only 20 percent of available information 

about a patient’s cancer is used in the course of his or 

her care. 

“ this pooled information will not only allow physicians 

to identify and treat the specific subtypes of cancer, 

but will also allow scientists to better understand the 

causes of cancer and effects of treatment.” 

5

6 


associate director for 

minority heaLth & disparities 

Lucile L. Adams-Campbell, PhD, an 

internationally-recognized expert on 

health disparities, was recruited to 

Lombardi in June 2008. Just a few 

weeks after joining Georgetown, 

she was elected to the prestigious 

Institute of Medicine, one of science 

and medicine’s highest honors. 

A Washington, DC native and life- 

long resident, Dr. Adams-Campbell 

has devoted her career to identifying 

and working to address cancer 

health disparities through research, 

community outreach, and education. 

Before coming to Georgetown, she 

served as director of the Howard 

University Cancer Center, a leading 

minority-serving institution in the 

District of Columbia.

The Health Disparities Initiative 

the overarching goal of the Lombardi health disparities initiative is to actively engage in research focused on 

reducing cancer disparities in the district of columbia among the underserved and ethnic minority populations 

including african-americans, Latinos, and asian americans. the initiative will do so by facilitating, stimulating, 

and promoting synergy in addressing the biological and environmental basis of cancer health disparities via 

research, training, communication, and education. 

disparities �� Across the nation, the burden of can- 

cer disproportionately impacts minority and other 

underserved populations. This is especially evident in 

the District of Columbia, which has one of the highest 

cancer mortality rates in the United States. The objec- 

tive of the Health Disparities Initiative is to address the 

biological and social determinants of cancer disparities, 

with particular emphasis on cancer prevention and con- 

trol in the Washington metropolitan area. 

community �� The Initiative works in collaboration 

with a Community Advisory Board, comprised of 

members representing the District of Columbia’s eight 

wards. Board members include neighborhood resi- 

dents, community-based physicians, non-profit and 

community organizations, churches, members of the 

media, and government officials. Through these partnerships, 

focus groups and assessments are conducted 

to understand the community’s needs regarding their 

health experience. Already, the Advisory Board has 

helped identify several issues, including the need to 

educate parents about the new laws around HPV vaccination 

among 6th grade girls in the District. 

research �� Minorities and underserved populations 

are under-represented in cancer research. The Initiative 

will focus on community-based research to address the 

interplay between genetics, environment, and cancer 

that could potentially reduce cancer disparities among 

these communities. One area of particular focus is en- 

ergy balance, which includes nutrition, diet, and physical 

activity components. The Initiative is studying these 

factors coupled with genetics and biology in order to 

understand and ultimately reduce the high rates of 

obesity in the District, including its link to breast, prostate, 

and colon cancers. Through community-based 

participatory research, which enables the community 

to participate in all aspects of the research, they are developing 

culturally appropriate interventions to reduce 

these cancer disparities. 

disseminate �� The District of Columbia has the 

highest estimated percentage of individuals at the 

lowest literacy levels compared to any state in the 

nation. The combination of poor literacy rates and high 

cancer morbidity and mortality rates in the District warrants 

attention. With the goal of improving health for all 

populations in the District, the Initiative is implementing 

literacy programs and creating culturally appropriate 

educational materials that will improve access to 

evidence-based cancer information for minorities and 

underserved communities. 

between 2001 and 2005, the 

district of columbia ranked 

first in the nation for deaths 

due to prostate, cervical, and 

breast cancers. the initiative 

works in collaboration with a 

community advisory board to reach 

out to the underserved communities of 

Washington, dc, with an emphasis on 

those areas east of the river, which are 

particularly hard hit (highlighted in 

yellow). 

7

8 


Lombardi introduces an 

eLectronic medicaL record 

Wall cabinets lined with color-coded 

patient charts are now a thing of the 

past at Lombardi. In late 2007, the 

Lombardi clinic transitioned to Aria, 

an electronic medical record (eMr) 

information system. 

Designed specifically for oncology 

services, Aria aggregates a patient’s 

data into a single, organized medical 

chart. Nurses and physicians can 

access the most up-to-date infor- 

mation about their patients’ treatment 

from any computer terminal. 

Part of a national trend, Lombardi 

implemented its new eMr in asso- 

ciation with Washington Hospital 

Center’s Washington Cancer Insti- 

tute and franklin Square Hospital, 

both sister hospitals in the Medstar 

Health System. 

Clinical Trials 

clinical trials play an 

important role in both 

cancer research and 

care. they serve as the 

first step into the clinic 

for all new therapies, 

and represent the final 

stages of a long and 

careful research process. 

treatment advances �� Lombardi is home to a robust Phase 1 

clinical trials program, which offers access to the most advanced 

therapies for cancer. These drugs are often first-in-human studies and 

represent a critical step in drug development, from the laboratory to 

the clinic. As most standard cancer treatments were first studied in 

clinical trials, these studies provide an opportunity for the patient to 

receive a new type of treatment if his/her cancer does not respond 

to standard treatment or if there is no standard treatment available. 

Closely regulated by the Georgetown University-MedStar Health 

Oncology Internal review Board, Lombardi offers access to clinical 

trials throughout the network of MedStar Health hospitals, from 

Baltimore to Washington, DC.

one mission 

patient care 

research 

education 

community 

9

10 

patient care 

“ physicians treating 

this groWing population 

have a simple, 

but poWerful tool for 

improving outcomes 

Within their grasp— 

spending time to 

engage and involve 

older Women in their 

breast cancer care.” 

Jeanne mandelblatt, md 

research 

education community

Improving Care for Older 

Breast Cancer Patients 

In 2006, women age 65 or older made up half of new breast cancer patients, but 

in some settings they failed to receive the same care as younger women. Seeking 

to understand this disparity, Jeanne Mandelblatt, MD, MPH, associate director for 

population sciences conducted a study about older women with breast cancer. 

Dr. Mandelblatt found that, “Older women who perceive 

more ageism in their interaction with providers 

are less likely to receive radiation or chemotherapy.” 

But today, the percentage of women over age 65 

receiving chemotherapy exceeds the national average, 

according to a new study examining treatment decision- 

making by older women with early stage breast cancer. 

Dr. Mandelblatt, the study’s lead investigator, calls this 

“an unexpected finding.” The numbers suggest, “Older 

women are learning more about their disease and may 

be weighing the risks and benefits more thoroughly.” 

What accounts for this change? Better communica- 

tion between doctors and patients is linked to choosing 

to undergo chemotherapy. In Dr. Mandelblatt’s study, 

patients for whom the benefits from chemotherapy were 

unclear were placed into a “consider chemotherapy” 

group. Within this group, patients who reported a high 

research in practice: shared decision-makinG at Lombardi 

seventy-three year-old lee hubbard was diagnosed with breast cancer in april 

2008. When her breast surgeon at georgetown, constanza cocilovo, md, 

recommended she follow-up with an oncologist, she promptly made an appointment 

to see Jennifer eng-Wong, md. “there was never any question in my 

mind about whether i needed to get chemo,” she said. “dr. eng-Wong strongly 

recommended it, and i followed her advice.” now enrolled in a clinical trial, lee 

added, “my doctors and nurses have been very responsive, and i have been very 

happy with my care.” 

level of communication with their doctors were most 

likely to get supplementary chemotherapy after surgery. 

Study results clearly illustrate that patients are 

better able to weigh the risks and benefits of chemotherapy 

with their doctors’ advice. Breast cancer treatment 

“is a good example of a situation where shared 

decision-making would be appropriate since equally 

effective surgical choices exist and there is uncertainty 

about adjuvant therapy,” wrote Dr. Mandelblatt. 

Patients involved in shared decision-making also 

tended to be more satisfied with their treatment, 

according to Dr. Mandelblatt. “Physicians treating this 

growing population have a simple, but powerful tool 

for improving outcomes within their grasp—spending 

time to engage and involve older women in their breast 

cancer care,” she concluded. 

Lee Hubbard � 

11

12 

patient care research 

education community 

“ eWing’s sarcoma is rare. 

but our Work has the 

potential to improve 

treatment not only 

for patients With this 

disease but for others 

Who have cancers 

With similar molecular 

characteristics.” 

Jeffrey toretsky, md

Potential ewing’s Sarcoma Targeted 

Therapy Discovered 

for over ten years, Jeffrey Toretsky, MD, has sought a cure for ewing’s sarcoma, 

a rare childhood cancer resulting from a mutation that swaps genes between two 

chromosomes. In 2008, he made a major breakthrough when he discovered a 

small molecule that could be the basis of a new therapy. 

The small molecule interrupts binding between 

the mutated protein, called eWS-fLI1, and one of its 

binding partners. Dr. Toretsky and his team had identified 

the binding partner in 2006, and working with 

Georgetown’s Drug Discovery Program, led by Milton 

Brown, MD, PhD, they identified the new molecule, 

which fills in the “keyhole” on eWS-fLI1 like wax might 

block a key from entering a lock. This halts the growth 

of ewing’s sarcoma cancer cells. While several stages 

of the research process remain before the drug can 

move into the clinic, this could be the first targeted 

therapy to be developed for ewing’s sarcoma. 

ewing’s sarcoma is diagnosed in approximately 500 

children each year. Because of the relatively small num- 

ber of patients diagnosed with the disease, there has 

been little research investment into new treatments. 

So-called “orphan” diseases such as ewing’s garner 

little interest from pharmaceutical companies who most 

Go4theGoaL foundation 

go4thegoal foundation was founded in 2006 by richard & beth 

stefanacci when their oldest son richard was diagnosed with 

ewing’s sarcoma at age 13. through the foundation, the stefanaccis 

became loyal supporters of dr. toretsky in 2007, giving nearly 

$150,000 for instrumentation and a staff member, which greatly 

expedited his research. according to the stefanaccis, “We were 

able to give richard everything but a cure! after his death we were 

committed to help find a cure and help children affected by cancer. 

Within minutes of meeting dr. toretsky we knew his lab was the 

perfect fit to achieve our foundation’s goal.” 

often conduct drug development research. Lombardi’s 

Drug Discovery Program provides an academic solution, 

enabling basic laboratory research, like Dr. Toretsky’s, 

to progress closer to clinical trials. 

Since 1999, The Children’s Cancer foundation has 

supported Dr. Toretsky’s research, believing in the 

promise of his approach. Their early support for his 

revolutionary work contributed to the major successes 

of the past year, which include additional peer-reviewed 

funding. 

In early 2008, the Burroughs-Wellcome fund— 

an independent private foundation—awarded him a 

prestigious Clinical Scientist Award in Translational 

research worth $750,000. The NIH also recently 

funded a third r01 grant for Dr. Toretsky, which focuses 

on the role of cancer stem cells in the development of 

ewing’s sarcoma. 

�Stefanacci family 

13

14 

patient care research education 

community 

“ We alWays enJoy having 

the felloWs around. 

there’s a certain energy 

and optimism at lombardi 

that you Wouldn’t find 

in a private practice 

environment. it makes 

the training experience 

more interesting and 

valuable.” 

Jimmy hwang, md

Leading fellowship Program Trains 

Next Generation of Oncologists 

Lombardi’s Hematology/Oncology fellowship Program is one of the top cancer 

specialty training programs in the country. Balancing clinical training and research 

experience, the curriculum places fellows at the epicenter of cancer research. 

founded over twenty years ago, only four to five fellows are accepted to the program 

each year from a pool of over three hundred applicants. 

Attending physicians directly supervise each fellow’s 

three year training experience to develop the best clinicians 

and clinical investigators in the country. fellows 

spend up to two years doing clinical work, seeing 

patients in a variety of contexts, and the remaining year 

conducting research. Upon completion, the fellows are 

able to practice in both medical oncology and hematology 

because the program is accredited for subspecialty 

training as a combined program by the Accreditation 

Council for Graduate Medical education. 

While there are many other combined hematology/ 

oncology programs in the country, Lombardi’s is unique 

because of the wealth of research opportunities and re- 

sources available. each fellow has the opportunity to 

select training in clinical research or translational re- 

chief feLLoW dedicated to a career in academic medicine 

trishna goswami, md, was selected to serve as chief fellow of lombardi’s hematology/ 

oncology fellowship program for 2009. a graduate of mcp hahnemann university 

medical school (now drexel university college of medicine), dr. goswami completed 

her residency in internal medicine at georgetown university hospital before applying 

for the fellowship. “lombardi is a great training program because it maximizes clinical 

care and exposure to novel research,” she said. as a second year fellow, dr. goswami 

demonstrated exceptional leadership and communication skills in stressful situations. 

“We on the faculty look at the chief fellow as a paragon for the other fellows, trainees, 

and students,” said dr. hwang. “We thought dr. goswami was an outstanding choice 

for chief fellow. We are fortunate that she was willing to take on this responsibility 

and honor.” 

search, which focuses on connecting the dots between 

laboratory science and patient care. 

“It’s sort of like an apprenticeship, in which the fellows 

learn by seeing,” said Jimmy Hwang, MD, who is head 

of the fellowship Program and an attending gastrointestinal 

oncologist in the Lombardi clinic. 

fellows often take a leadership role in clinical meetings 

among physicians. Throughout their training, they 

are required to lead discussions about the latest advances 

in cancer care, and are asked to present cases 

for discussion by multidisciplinary teams of specialists. 

Graduates of the program include Lombardi’s Chief 

of Hematology/Oncology John L. Marshall, MD, and 

Breast Cancer Program Leader Claudine Isaacs, MD. 

�Trishna Goswami, MD 

15

16 

patient care research education 

community 

“ We Want people to 

knoW that breast 

cancer doesn’t mean 

you’re going to die, and 

that early detection 

can save your life.” 

michelle fenty

Capital Breast Care Center 

Provides 5000th Mammogram 

In 2008, Lombardi’s Capital Breast Care Center (CBCC) announced it had reached 

the landmark of 5000 women screened. The CBCC provides extraordinary quality 

care regardless of a woman’s ability to pay to underserved women in Washington, 

DC—a city in which women die from breast cancer at a rate of 65 percent above 

the national average; the highest death rate in the country. 

It was the devastating statistics in Washington, DC, 

which first attracted Michelle Cross fenty, JD, the first 

lady of Washington, DC, to serve as president of the 

CBCC Advisory Council. 

“The Capital Breast Care Center works to spread the 

message about the dire situation in Washington, DC, 

but also encourages women to get yearly mammograms,” 

said Mrs. fenty. 

Since opening its doors in April 2004, the CBCC has 

been supported by grants to Lombardi from the Avon 

foundation and the Washington, DC Department of 

Health, among others. The Center serves DC women 

who would otherwise not have access to vital services 

such as mammograms, genetic testing, patient navigation 

and quality care. 

“With support from Avon and others, our goal 

kesher nashim : a circLe of Women 

the members of kesher nashim, a hebrew term meaning “a circle of women”, are 

breast cancer survivors from congregation beth el of montgomery county, md. 

providing support for those newly diagnosed as well as survivors, kesher nashim 

also supports the efforts of the cbcc. the group raised over $5,000 for the cbcc’s 

2008 gift of life breakfast—one of the highest grossing tables at the event. “We 

have a very personal affinity and connection to the women that the center serves,” 

said susan Winarsky. “it’s not a remote concept, and we know how difficult it is to 

navigate our complex healthcare system.” 

Susan Winarsky, Margaret Rifkind, Naomi Greenwood, and Margery Landon, members of Kesher Nashim � 

is to make sure that all women in the Washington 

metropolitan region learn about breast cancer, dispel 

myths and misperceptions, and foster healthy lifestyles 

including access for all women to receive breast cancer 

screening,” said Peter Shields, MD, deputy director of 

Lombardi and senior medical director of the CBCC. 

The Center uses a three-pronged approach to combat 

breast cancer: offering screening to underserved 

and uninsured women, providing a patient navigator to 

support women who receive a diagnosis of cancer, and 

educating women throughout the community about 

breast cancer risks and the need for screening. 

“everyone has lost someone to breast cancer—it’s a 

disease that everyone can relate to. My goal is for every- 

one in the city to know that the CBCC is somewhere to 

get screened,” said Mrs. fenty. 

17

18 

lombardi leadership 

directors 

peter g. shields, md 

Deputy Director 

Professor of Medicine & Oncology 

department chairs 

louis m. Weiner, md 

Chair 

Department of Oncology 

gregory gagnon, md 

Chair 

Department of Radiation Medicine 

françoise sellier-moseiwitsch, phd 

Chair 

Department of Biostatistics, 

Biomathematics, and Bioinformatics 

c. richard schlegel, md, phd 

Chair 

Department of Pathology 

louis m. Weiner, md 

Director 

Georgetown Lombardi 

Comprehensive Cancer Center 

John l. marshall, md 

Associate Director for 

Clinical research 

Associate Professor of 

Medicine & Oncology 

anton Wellstein, md, phd 


Basic Science 

Professor of Oncology & 

Pharmacology 

research program leaders 

breast cancer 

robert clarke, phd, dsc n claudine isaacs, md 

Jeanne mandelblatt, md, mph 


Population Sciences 

Professor of Medicine & Oncology 

The Breast Cancer Program is a clinical translational research 

program dedicated to identifying better methods of diagnosis, 

treatment, and prevention of breast cancer. The Nina Hyde Center 

for Breast Cancer research, part of the Breast Cancer Program, is 

home to more than 50 Lombardi scientists and physicians striving 

to uncover the biological basis of the many faces of breast 

cancer and working toward its prevention and cure. Georgetown 

University has been consistently ranked in the top 10 institutions 

conducting breast cancer research as measured by eSI Thompson 

Scientific. 

cancer controL 

marc schwartz, phd 

The Cancer Control Program conducts research across the range 

of the cancer control process from risk factors and prevention, 

through early detection, to treatment and survivorship. Lombardi’s 

program is unique in its inclusion of populations across the lifespan—from 

childhood to older age—and translation from the cellular 

to the societal and policy level. The overall goal of the program 

is to develop, evaluate and disseminate innovative cancer control 

interventions designed to reduce the incidence, morbidity, and 

mortality from cancer among high-risk populations.

anna t. riegel, phd 


Cancer research education 

Professor of Oncology & 

Pharmacology 

stephen byers, phd 

Director of Shared resources 

Professor of Oncology 

carcinoGenesis, biomarkers & epidemioLoGy 

christopher loffredo, phd n fung-lung chung, phd 

The Carcinogenesis, Biomarkers and epidemiology Program’s 

mission is to understand the body’s response to carcinogenesis. 

The program focuses its research primarily on the genetic and 

environmental factors which affect the development and progression 

of cancer, identifying markers for risk and methods for 

prevention. The goal of the program is to understand and reduce 

cancer incidence, morbidity, and mortality by understanding the 

basis of risk, host response, and carcinogenic processes across 

the cancer spectrum (cancer development, early disease progression 

and survival). 

druG discovery & deveLopmentaL therapeutics 

milton brown, md, phd �� John l. marshall, md 

The Drug Discovery and Developmental Therapeutics Program 

focuses on the identification and development of novel cancer 

treatments. In this program, basic scientists and clinicians collab- 

orate to provide Lombardi faculty members with a conduit for 

rapid, scientifically-driven cancer drug development. The program 

is organized as a drug development “pipeline” with expertise in drug 

and target discovery, the performance of innovative early Phase 

clinical research, and disease-specific Phase II and III clinical 

research. 

michael p. vander hoek, mhsp 


Administration and Planning 

lucile l. adams-campbell, phd 

Associate Director for Minority 

Health and Health Disparities 

Professor of Oncology 

GroWth reGuLation of cancer 

priscilla furth, md n c. richard schlegel, md, phd 

The overall scientific goal of the Growth regulation of Cancer 

Program is to understand the molecular determinants of the path- 

ophysiological pathways that lead to cancer development. The 

research focuses on two basic principles—the processes of cancer 

initiation and prevention. Specifically, researchers are dedicated 

to understanding the role of growth factor and hormonal path- 

ways, determinants of cell fate, as well as the role of virology in 

carcinogenesis. The program’s approach is to define the molecular 

mechanisms that govern cancer development. 

moLecuLar tarGets and therapeutic resistance 

vicente notario, phd �� eliot rosen, md, phd 

As a basic science research program, Molecular Targets & Therapeutic 

resistance focuses on the mechanisms of therapeutic re- 

sistance in tumor and normal cells, including responses to radiation, 

chemotherapy agents, and hormonal agents. The ultimate 

goal is to apply the basic knowledge gained from these studies to 

improve therapeutic interventions. The overall conceptual framework 

of the program is based on the idea that signaling abnormalities 

in cancer are the same defects that affect responses to 

conventional treatments. 

19

20 

year in revieW 

expressive WritinG improves patient’s WeLLbeinG 

Writing about thoughts and feelings related to cancer not only changes the way cancer 

patients view their disease, but also benefits both their physical and mental health. “We 

found that just one writing session in a busy cancer clinic where the patients are frequently 

interrupted can still have a positive impact on patients,” said Nancy P. Morgan, MA-TLA, 

writing clinician and director of the Lombardi Arts and Humanities Program. Ms. Morgan 

and her colleagues conducted their study in the clinic waiting area at Lombardi. “I’m pleased 

to see that so many of our patients were interested in this kind of therapy,” said Bruce 

Cheson, MD, head of hematology at the Cancer Center. “Our study supports the benefit of 

an expressive writing program and the ability to integrate such a program into a busy clinic.” 

Lombardi pubLishes book for chiLdhood cancer survivors 

The Next Step… Crossing the Bridge to Survivorship is an educational guide designed 

to serve as a long-term resource for pediatric cancer suvivors, with extensive information 

about the “late effects” of treatment, which may occur many years after 

therapy is completed. “The end of cancer treatment is a time of strong emotions 

for patients and families,” said Aziza T. Shad, MD, chief of the division of pediatric 

hematology/oncology at Lombardi, and author of the book. “We hope this book 

will help ease the transition for patients and families from active treatment to 

follow-up care.” The handbook is customized for each patient to include information 

about their cancer diagnosis and specific treatments. 

Genetic testinG and the importance of discussinG cancer history 

Whether or not relatives talk about a family’s history of cancer significantly impacts attitudes 

and knowledge about genetic counseling and testing for those at moderate risk of developing 

cancer. A recent study conducted by Kenneth Tercyak, PhD, at Lombardi’s fisher Center for 

familial Cancer research found that mothers who decided to share breast cancer genetic testing 

results with their children were more satisfied with their decision than those who decided 

not to disclose the results. for common cancers, such as breast, colon, and prostate cancer, 

20–30% of those affected have a family history of these cancers. Genetic counseling and testing 

may be obtained to learn more about cancer risks and options for cancer screening and 

prevention. 

test can heLp doctors determine treatment chanGes earLier 

A simple blood test could tell women with advanced breast cancer whether or not their treatments are 

working earlier and more reliably than current methods. Under the direction of Minetta Liu, MD, medical 

oncologist and director of translational breast cancer research at Lombardi, researchers measured the 

number of circulating tumor cells (CTCs) in blood collected from women with metastatic breast cancer. 

The number of CTCs, measured by the fDA-approved CellSearch technology, was correlated with disease 

response or progression. “The key is to find the most effective therapy for each patient. It shouldn’t 

take months to figure that out,” Dr. Liu concluded.

patient care 

research 

anatasha craWford seLected for bouchet society 

Anatasha Crawford, a doctoral student in Lombardi’s Tumor Biology 

Training Program, has been named a member of the prestigious edward 

A. Bouchet Graduate Honor Society. The Bouchet Society aims to recog- 

nize outstanding scholarly achievement and promote diversity and excel- 

lence in doctoral education and the professoriate. Ms. Crawford’s dissertation 

focuses on how and why cancer becomes resistant over time to 

therapy, specifically looking at resistance to antiestrogen treatments for 

breast cancer. “I believe that my scholarship, leadership, character, ser- 

vice, and advocacy will help me become an accomplished breast cancer 

research scientist and more importantly a successful mentor,” she said. 

She plans to continue to work in her community and as an advocate for 

increasing the presence of minorities in PhD programs in the field of 

biomedical research. 

teaminG up to prevent prostate cancer 

every year during national prostate cancer awareness week, the Department 

of Urology at Georgetown University Hospital and the Georgetown Lombardi 

Comprehensive Cancer Center offer free prostate cancer screening. In 2008, 

nearly 200 men were screened by an all-volunteer staff that included Georgetown 

University medical students and Hospital physicians. This year, the Department of 

Urology added a new screening test to the traditional PSA test and the digital rectal 

exam, which requires only a small blood sample to be drawn, and reduces the 

number of false-positive results. The screening has been funded by the generosity 

of the NfL Charities for the past ten years. 

education community 

robert clarke, phd, dsc, mentored both anatasha 

crawford and Zachary dobbin, a Georgetown 

university undergraduate student, in his laboratory 

at Lombardi, which is dedicated to understanding 

the molecular biology of breast cancer. 

empoWerinG underserved patients 

In the United States, African American and Latina women are diagnosed with breast cancer 

less frequently than white women. But studies show that once diagnosed, these women are 

more likely to die of their disease. Vanessa Sheppard, PhD, an assistant professor at Lombardi, 

has developed Sisters Informing Sisters and Latina a Latina, two programs dedicated to helping 

African American and Latina breast cancer patients make informed decisions about their 

treatment. Both programs match patients with patient navigators—often breast cancer survivors 

themselves—who navigate women through the treatment decision process. “I understand 

how difficult a time getting a diagnosis is in someone’s life. I want to make sure that women 

receive the support they need, and reduce—if not eliminate—disparities in healthcare,” Dr. 

Sheppard said. 

21

22 

M I L L I O N S $ 

40 

by the numbers 


N U M B E R O F P A T I E N T S 

P A T I E N T V I S I T S 



80 

60 

40 

20 

0 

0 

research 600 funding: 2004–2008 

600 

100 

500 

80 

400 

60 

300 

40200 

100 

20 

600 

500 

30,000 

0 

50,000 

0 

40,000 

30,000 

20,000 

0 

2004 

10,000 400 


100 

80 

60 

40 

20 

0 


300 

2004 

200 

600 

2004 

2005 

500 

400 

300 

200 

100 

0 

2005 

2005 

2006 

2006 

400 

patient visits: 2004–2008 

50,000 

300 

50,000 

200 40,000 

40,000 

100 30,000 

100 

20,000 

80 

10,000 


0 

2004 

60 

0 

40 

20 




600 

500 

100 

60 

20 


2004 

0 

0 


500 

400 

300 

200 

2004 

100 

2005 

0 

20,000 

10,000 

Gastrointestinal 

50,000 

40,000 

30,000 

20,000 

0 


2004 

10,000 

0 

2004 

2005 

2004 

2005 

2006 

Breast 

Genitourinary 

2005 

2006 

2006 

2007 

2006 

2007 

2007 

Lung 

Hematologic 

2007 

2007 

2007 

2008 

2008 

Neurological 

2008 

Head & Neck 

2008 

2008 

2008 

Endocrine 

P A T I E N T S E N R O L L E D 

8000 

7000 

6000 

5000 

4000 

3000 

2000 

1000 

0 

sources of research funding: 2008* 

Skin 


Gynecologic 


8000 

7000 

6000 

5000 

4000 

3000 

2000 

1000 

Interventional 

0 

8000 

7000 

6000 

5000 

4000 

3000 

2000 

1000 

Orthopedic 

T YPE OF TRIAL 

0 

Unknown 

Other 

4000 

Non-interventional 

3000 


1000 


n 53% nih 

n 25% other peer-reviewed 

(from government and 

foundations) 

n 21% NIH industry 

n 1% other 

TYPE OF TRIAL 

TYPE OF TRIAL 


Industry 




Industry 

Other peer-rev 

NIH 


Industry 

Other peer-reviewed (from government and foundations) 

Other peer-re 



Breast 

Breast 

Genitourinary 

Genitourinary 

Lung 

Lung 

Hematologic 

Hematologic 

Neurological 

Neurological 

Head & Neck 

Head & Neck 

Endocrine 

Endocrine 

Skin 

Skin 

Gynecologic 


Gynecologic 

Orthopedic 

Breast 

Orthopedic 

Unknown 

Genitourinary 

Unknown 


Lung 


Hematologic 

Neurological 

Head & Neck 

Endocrine 

Skin 

Gynecologic 

Orthopedic 

Unknown 


2006 

2007 

2008 

neW patients by cancer type: fy2008* 

Breast 

2005 

Genitourinary 

2005 

2006 

Lung 

2006 

Hematologic 

2007 

2007 

Neurological 

2008 

2008 

Head & Neck 

Endocrine 


Data are for calendar year spans unless otherwise noted. 

8000 

7000 

6000 

5000 

2000 

Skin 

0 

Gynecologic 

*Does not include philanthropic support. 

clinical trial enrollment: 

2008 


Orthopedic 

TYPE OF TRIAL 

Unknown 



*fiscal year is July 1, 2007 through June 30, 2008. 

NIH 


Industry 

Other pe 

NIH 

In 

O 

N

honor roll of donors 

Lombardi’s successes, from the growth of new initiatives to the latest advances in 

patient care, would not be possible without the generous support of so many in the 

community. We thank you all for generous contributions to the success of Lombardi 

in our fight against cancer, and recognize those gifts received during fiscal year 

2008 (July 2007 through June 2008). 

$100,000–$999,999 

American Cancer Society 

Avon foundation 

The Children’s Cancer foundation 

Marshall B. Coyne foundation 

Bernard & Sarah Gewirz 

foundation, Inc. 

Marvin and Jo Anne McIntyre family 

foundation 

NfL Charities 

Prevent Cancer foundation 

Prince Charitable Trusts 

elisabeth von Matsch through the 

edwin H. richard Trust 

Dr. Scholl foundation 

$10,000–$99,999 

3M Company Inc. 

Tina S. Alster, M.D. 

American Association for Cancer 

research 

American Institute for Cancer research 

Ms. rebecca M. Bednarik 

Beers + Cutler, PLLC 

Carefirst BlueCross BlueShield 

Cherry Blossom Breast Cancer fund 

Ms. Patricia Loughrey and Mr. John D. 

Claringbould 

The Clark Charitable foundation 

Comcast financial Agency Corporation 

DBTS Inc. 

Donohue family foundation 

Douglas Development 

Mary Joy Drass, M.D. 

Drueding foundation 

ermenegildo Zegna Group 

first Potomac realty Investment, LP 

r. J. fox foundation 

Dr. and Mrs. richard C. fuisz 

Dr. and Mrs. Arthur f. furman 

Genworth financial 

Giant food LLC 

Global Transportation Systems Inc. 

Go Bo fund 

Go4theGoal foundation 

Ms. Judith G. Gordon 

Heritage Charity Classic 

Stuart and Daphne Himelfarb 

Hope On Wheels Hyundai Dealers 

Integral Nuclear Associates, LLC 

Mr. and Mrs. John Jaffe 

The JBG Companies 

The Joseph e. and Marjorie B. Jones 

foundation 

Governor and Mrs. francis A. Keating, II 

Mr. Neil S. Kishter 

Mr. William H. Klinedinst 

Nathan Landow family Limited 

Partnership 

Jeffrey and Mary Lane 

ralph and ricky Lauren 

Macy’s Inc. 

MedStar Health Inc. 

Mr. and Mrs. Herbert S. Miller 

Miller’s furs 

National Cancer Prevention fund 

Mr. William Naughton 

Newman’s Own foundation 

Parkway Ventures Inc. 

Patty Pollotas fund Inc. 

Pink Skirts - Andy Horne 

Polo ralph Lauren foundation 

The John and Jane Powers foundation 

Mr. Perry D. Quick 

Sylvia ritzenberg Charitable Trust 

Mr. and Mrs. frederick D. Schaufeld 

rolls-royce 

The Hon. and Mrs. ronald rosenfeld 

rTKL Assoc., Inc. 

Ms. Maria Stella ruggirello 

Mrs. frances Schafer 

Mr. Michael e. Schaufeld 

Seagears family foundation 

Liddy Shriver Sarcoma Initiative fund 

Smithfield foods Inc. 

Swing fore the Cure 

Mr. and Mrs. John r. Thompson III 

Norma Kline Tiefel foundation 

Tishman Speyer Properties, LP 

UnitedHealthCare Services Inc. 

Mrs. Anne C. Whittington 

$1,000–$9,999 

Abitibi-Consolidated Company of 

Canada 

The Abramson family foundation 

Acacia federal Savings Bank 

AeP Georgetown fraternity 

AgencyOne Insurance Marketing Group 

Albert & Lillian Small foundation 

Mr. and Mrs. William B. Alsup 

American foundation 

The American Legacy foundation 

American Trucking Associations Inc. 

Mr. and Mrs. richard Amons 

Susan M. Ascher, M.D. 

The Baker foundation 

Ms. Sarah e. Baker 

Bancroft Associates, PLLC 

Ms. Carie-Ann D. Barrow 

Gabriel Battista 

Baystate financial Services LLC 

Mr. John A. Beck 

Bender foundation, Inc. 

Mr. and Mrs. robert H. Benna 

The Hon. and Mrs. Stuart A. Bernstein 

Blake real estate, Inc 

Jay and ellen Bloom fund 

Mr. and Mrs. Jay B. Bloom 

Boland 

Mr. and Mrs. Benjamin W. Boley 

Mr. William J. Boylan 

BP Corporation North America Inc. 

Mr. Keith D. Brown 

Mrs. Peggy S. Brown 

Salvatore and Cynthia Bruno 

Mr. and Mrs. Thomas L. Buckmaster 

Mr. and Mrs. robert V. Cahill 

Dr. and Mrs. Nils W. Carlson 

e. eugene Carter foundation 

Mr. Z. J. Chelec 

Cissel-Saxon Unit No. 41/American 

Legion Auxiliary 

Mr. and Mrs. George P. Clancy 

Clark Construction Group, LLC 

Click Wine Group 

Ms. Deborah e. Cochrane 

Mr. richard S. Cohen 

23

24 


Mr. Sherman L. Cohn 

Congressional Institute Inc. 

Core Capital Partners 

Corporate Office Properties Trust 

Corstone Capital Corporation 

The Hon. Carol T. Crawford and Mr. 

ronald Crawford 

Daffodils & Diamonds 

DBI Architechts Inc. 

Mr. David Deckelbaum 

Mr. and Mrs. Mark O. Decker, Sr. 

Captain Victor Delano, USN (ret) 

Dr. and Mrs. Daniel L. Dellatore 

Ms. Jo Ann Grainger and Mr. John 

Devlin 

Ms. Kerry Diamond 

Mr. and Mrs. robert r. Dickson 

Ms. Judith Diesenhaus 

Joanna ritcey-Donohue and William 

Donohue 

Mrs. Jeanne C. Donovan 

Ms. Victoria J. Doran 

The Max and Victoria Dreyfus 

foundation 

Mr. and Mrs. Ken Druskin 

Mr. Seth Dudley 

Mr. and Mrs. Albert J. Dwoskin 

e. Goodwin & Sons Inc. 

edison electric Institute 

american airLines 

Mr. Douglas egan 

The Jonathan S. & Patricia G. england 

foundation 

eTA 

Mrs. Jeanette Perno fenty 

Jean-Marie ferenz and raul fernandez 

Mr. Douglas fleit 

fleming Jenkins Vineyards & Winery 

fosterSoft, Inc. 

Les francis Photography 

Dr. Irma and Mr. richard frank 

Mr. Scott A. frankel 

freddie Mac foundation 

Ms. Linda fuselier and Mr. Chris Ogden 

The Hon. and Mrs. Arthur J. Gajarsa 

Mary L. Gardner, M.D. 

Ms. Mickela D. Gay 

Mr. and Mrs. Carl S. Gewirz 

Ms. Karen e. Griffith Gilbreath and Mr. 

Jim Sowell 

Ms. Lisa W. Gill 

Gladstone Management Corporation 

The Glenstone foundation 

Mrs. Gretchen Meister Gorog 

Mr. James B. Graham 

The Hon. and Mrs. William Graves 

Mr. William f. Greaney 

Greater Washington Commercial 

Association of realtors 

for nearly two decades, american airlines has supported lombardi with more than 

$250,000 in airline tickets. as the official airline for both the Women and Wine and 

the men’s event in 2008, american airlines flights were auctioned and raffled to help 

raise funds for the cancer center. 

the Women & Wine event is a high profile occasion that affords a prestigious 

group of women the opportunity to enjoy an evening among their peers, in an upscale 

dinner setting, while raising significant dollars in support of women’s cancers. tickets 

from american airlines were offered as door prizes to lucky attendees. the men’s 

event, focusing on prostate cancer awareness, was also sponsored by american 

airlines. 

“american airlines has long been an avid supporter of the lombardi compre- 

hensive cancer center. We traditionally look for organizations that are totally com- 

mitted to providing unyielding support and relief to the communities,” said gerald 

mcgaughey, regional sales director for the mid-atlantic. “lombardi has been relentless 

and unwavering in their contributions to patient care and cancer research. We 

truly appreciate the commitment and dedication that they continue to provide.” 

american airlines has also been the official airline of the lombardi gala since 

2005. the company has donated dream vacations to the live auction, including all 

expenses paid first class tickets to shanghai, london, and the galapagos islands. 

Mr. and Mrs. Arthur Greenberg 

Mr. and Mrs. richard O. Haase 

A. J. Harris, II Charitable foundation 

Harvey-Cleary Builders 

Ms. Joyce Havard 

Mr. and Mrs. John T. Hazel, Jr. 

Health Insurance Specialists 

Heart Sing foundation 

Ms. elizabeth C. Arbogast and Mr. 

Walter L. Hill 

Hogan & Hartson, LLP 

The Home Depot USA 

Mr. Steven B. Hopping 

Mr. and Mrs. Joseph f. Horning 

Mr. George C. Howell, III 

Hunton & Williams, LLP 

Ms. Jane L. Sprol Hurley 

Independent Project Analysis Inc. 

Innovative Management & Technology 

Approaches Inc. 

Mr. and Mrs. Benjamin r. Jacobs 

Jamaican Women of Washington Inc. 

Jeff Lubin Studios 

Johnson & Johnson 

Clarion e. Johnson, M.D. 

Ms. rosalind Juo 

K & L Gates 

Mr. Joseph W. Kaempfer, Jr. 

Mr. and Mrs. Joe Kampf

doo Wop concert for cancer 

more than 60 doo Wop and rock ‘n’ roll performers from across the country took the stage at 

the district’s historic Warner theatre on saturday, september 6, 2008 to benefit the pancreatic 

and prostate programs at the georgetown lombardi comprehensive cancer center. over 1,500 

guests were in attendance at the first-ever lombardi doo Wop concert for cancer. 

the event raised $600,000 and honored the memory of commercial real estate advisor and 

doo Wop fan eddie geisinger, who lost his battle with pancreatic cancer in 2001 at the age of 

55. marvin mcintyre of smith barney was the presenting sponsor of the concert with a gift of 

$100,000. 

“prostate and pancreatic cancers affect thousands of americans each year. With the support 

of the community with events like this, lombardi will continue to be able to conduct world-class, 

cutting-edge research and will provide superb, compassionate patient care that builds on its base 

of research excellence,” said louis m. Weiner, md, director of lombardi. 

Mr. Brian L. Katz 

Timothy Dyk & Sally Katzen family fund 

Mr. and Mrs. Howard J. Kaufman 

Keller & Heckman, LLP 

Mr. and Mrs. James J. Kelley 

Mr. e. Douglas Kenna 

Kirkland & ellis, LLP 

Korzeniewski family foundation 

Mr. and Mrs. robert Korzeniewski 

Kovak foundation 

Labat-Anderson, Incorporated 

eugene W. and Gloria Landy family 

foundation 

Mr. and Mrs. Jerome Lauren 

Ms. Yen-Yao Lee 

Mr. and Mrs. Craig Lemle 

Annette M. & Theodore N. Lerner family 

foundation Inc. 

Mr. Michael J. Lindner 

The Livingston Group, LLC 

Sally and Vincent Lombardi 

Michael P. Lorek, M.D. 

The Loyola foundation, Inc. 

Mr. and Mrs. J. Christopher Lynch 

Magna Carta foundation 

The Malek family Charitable Trust 

Dimitri and Peggy Mallios 

Ms. Theresa D. Mangen 

Ms. Catherine Marich 

Marks Insurance & Associates Inc. 

Mr. David S. Martin 

The Maxwell Taylor foundation 

Irving May & edith H. May foundation 

Mayer Brown, LLP 

Marybeth McAteer, M.D. 

Cathy and Scot McCulloch 

Mrs. Mary M. McDonough Connolly 

Sammy Sax and the MDs perform at Lombardi’s Doo Wop Concert � 

Kevin G. McGeagh, M.D. 

Michelle Dupont Inc. 

Mr. Andrew L. Moose 

Morgan Stanley Matching Gifts Program 

Mr. James Muldoon 

ellen and Jim Myerberg 

National Association of Chain Drug 

Stores, Inc. 

The National Italian American foundation 

National rehabilitation Hospital 

Ms. Diane Newberg 

Newmark Knight frank 

Mr. and Mrs. Henry e. Nichols 

Nolan family Charitable foundation Inc. 

Mr. and Mrs. Phillip G. Norton 

Oakdale emory United Methodist Church 

The Terrence & Margaret O’Donnell 

Charitable Gift fund 

The Otto Company 

The Owen family foundation 

Mr. and Mrs. Victor W. Palmer 

PCC-ACNA 

Pfizer 

PGA Tour, Inc. 

Pillsbury 

Plastic and reconstructive Surgery 

Ms. Joan Plotkin 

John J. Pohanka family foundation 

Mr. Charles A. Post 

Potomac electric Power Company 

Potomac Partners 

Mr. Charles Owen Prince, III 

Property Capital, LLC 

randall Hagner, Ltd. 

robyn redfield 

Phillip renfrow 

republic Title, Inc. 

The reserve 

retirement Planners and Administrators, Inc. 

Mr. Ken rietz 

The Michael L. riordan fund 

Mr. and Mrs. Paul Anthony ritacco 

James & Trisha ritzenberg 

The rLJ Companies, LLC 

roadcap family Limited Partnrship 

Mr. robert K. robbins 

Carter and Jackie roberts 

Ms. Terri robinson 

Mr. Samuel G. rose 

Ms. rosemary rosso 

ryland 

S. Kann Sons Company foundation, Inc. 

Saint Mary’s 

Shahram Salemy, M.D. 

Mr. Gene Samburg 

Mr. and Mrs. John Sanders 

Mr. Mitchell N. Schear 

Mrs. Gerda Schechter 

The Scherr family fund 

Mr. Bob Schieffer 

Ms. Julie Burt Schuelke 

Paul and randi Schweitzer 

Science Applications International Corp. 

(SAIC) 

Second Chance employment Services 

Nancy and Ali Sevin 

The Shafran family foundation 

Shapiro, Lifschitz and Schram, PC 

Mr. and Mrs. Bernard M. Shapiro 

Mr. Donald J. Shepard 

Ms. elizabeth Shepard and Mr. Terrence 

D. Straub 

Peter G. Shields, M.D. 

Mr. Patrick Shooltz 

25

26 


Mr. Thomas C. Shooltz 

Mrs. Winifred Shreeves 

Shulman, rogers, Gandal, Pordy & 

ecker, PA 

Mr. robert Silverman 

Caren Singer foundation for Breast 

Cancer research 

Mr. Terry Slease 

Jennifer and erik Smulson 

Mr. Tony Snow 

Mr. and Mrs. Mitchell Spaid 

Mr. Charles M. Steiner 

Stephen G. Yeonas Company 

Mr. Guy Thomas Steuart, II 

Studley, Inc. 

Ms. Kathleen Murphy and Mr. William 

Sudow 

SunTrust Mid-Atlantic foundation 

Symantec Corporation 

elizabeth Tanzi, M.D. 

Mr. and Mrs. Gary f. Temple 

Thomas rutherfoord Inc. 

Ms. Susan M. Thomas 

Timbervest, LLC 

robert e. and Anne P. Torray family 

foundation 

United Bank Card Inc. 

United States Steel Corporation 

U.S. Chamber of Commerce 

Mr. and Mrs. Jonathan r. Veum 

Vornado/Charles e. Smith 

Wachovia Corporation 

The Washington Post Company 

Washington real estate Investment 

Trust 

Washington Wellness Institute, PC 

Watt, Tieder, Hoffar & fitzgerald, LLP 

Wilkes, Artis, Hedrik & Lane, Chtd. 

Williams and Connolly 

Mrs. Agnes N. Williams 

Windows Catering Company 

Mr. and Mrs. Stephen Witort 

Mr. David C. Wright 

Ms. elizabeth Jane Yeates 

Mr. Stephen Thomas Yelverton 

Mr. and Mrs. John Yochelson 

Mr. and Mrs. Shariar Zaimi 

Mr. richard Zitelman 

$500–$999 

Ms. Tanya Potter Adler and 

Mr. Howard B. Adler 

AIG 

Mr. and Mrs. richard S. Alexander 

Mr. Charles M. Anopf 

APSP - Middle Atlantic Chapter 

Velvie Pogue and Alfred Ashford 

The Association Of Boarding Schools 

Mr. Wade H. Atkinson, Jr. 

Ms. Kellie Ballard 

Mr. and Mrs. richard D. Bean 

Ms. Jane C. Bergner 

the richard von matsch endoWed chair 

in experimentaL therapuetics Milton Brown, MD, PhD � 

milton l. brown, md, phd, was named the inaugural edwin h. richard and elisabeth 

richard von matsch endowed chair in experimental therapeutics on January 17th, 2008. 

dr. brown leads georgetown university’s drug discovery program, which aims to narrow 

the gap between the discovery of tools that improve our knowledge of diseases and the 

number of new therapies “translated” to the bedside. 

the endowed chair is part of a $4.5 million gift from mrs. elisabeth richard von 

matsch and the richard family to support clinical and translational research in drug discovery 

and development at georgetown university medical center. dr. brown has devoted 

his career to developing drugs to treat diseases ranging from cancer to seizure disorders 

to hypertension. as chair, he will continue to lead georgetown’s thriving drug discovery 

program in its mission to develop lifesaving diagnostics and therapeutics. 

“i am really grateful for the generous support of the richard family,” said dr. brown, 

who is an associate professor of oncology and neuroscience. “their generosity will help 

us solidify the foundation of one of the only academic drug discovery programs in the 

country, leading to the creation of many new compounds aimed at helping people live 

healthier lives.” 

Bishop Ireton High School 

Bonner, Kiernan, Trebach & Crociata 

Mr. Michael J. Bowen 

Ms. Doris J. Brown 

Mr. and Mrs. William L. Bryant 

Mr. Quang Minh Bui 

Mr. fred Caesar 

The Morris and Gwendolyn Cafritz 

foundation 

Mr. and Mrs. Kenneth Carpenter 

Mr. and Mrs. James Carr 

Mr. roasrio Castioni 

Mr. Wayman W. Cheatham 

Ms. Julia Ciorletti 

Peter I. and Jane M. Cohen fund 

Jessie Margolis and Thomas Coleman 

Comcast 

Mr. David M. Curry 

Mr. and Mrs. robert L. Curtis 

Dan Pacific Hotel Seattle 

The Hon. Samuel H. Dean 

Mrs. Carolyn Deaver 

Mr. Michael Stephen Diamant 

Mr. and Mrs. Jeffrey S. Distenfeld 

Cornell Douglas foundation Inc. 

Mrs. Joan W. Doyle 

Mr. edmund C. Duffy 

exxonMobil Corporation 

Mr. richard A. feinstein 

Mr. John D. ferguson 

Dr. and Mrs. Gregory John Gagnon

John potter 

on friday, october 3, 2008, over 100 family members, friends, and colleagues 

gathered to honor John f. potter, md, founder and first director of the lombardi 

comprehensive cancer center. dr. potter, a nationally recognized specialist in oncology 

and surgery, served the georgetown university medical community for 60 years. 

during his career, dr. potter published many scholarly articles, authored a book, and 

was president of the association of american cancer institutes. 

the event also marked the inauguration of the John f. potter distinguished 

lecture series named in his honor. John e. niederhuber, md, director of the national 

cancer institute, and a nationally renowned surgeon and researcher, was the keynote 

speaker. the topic of dr. niederhuber’s lecture was “frontiers of cancer research.” 

in 1970, dr. potter became the first director of the lombardi cancer center, which 

he founded in memory of the legendary green bay packers and Washington redskins 

football coach vincent t. lombardi. during his 20 year tenure, the center received its 

comprehensive designation in 1974. 

Dr. Potter with Lombardi’s current director, Louis Weiner, at the ceremony honoring his leadership � 

The Hon. Marvin J. Garbis 

Ms. elise A. Gemeinhardt 

Mr. and Mrs. Wayne B. Gifford 

Mr. and Mrs. H. Jason Gold 

Dr. and Mrs. John f. Griffith 

Mr. and Mrs. Bill r. Gulsby 

Mr. David Svend Gusmer 

Mr. John Harkrider 

Mr. C. edward Harshbarger 

Ms. Anne Hatfield and Mr. Howard Weir 

Ms. Heidi Hatfield 

Mr. Gary C. Hufbauer 

Mr. and Mrs. Michael J. Hunter 

Ms. Jennifer Hyde and Mr. David M. 

Bronstein 

Mrs. Jean M. Iker 

International Paper employees Community 

fund 

Mrs. Anne Lise A. Jones 

Mr. Dan Katan 

Mr. and Mrs. James D. Kaufmann 

Mr. Brian J. Kearney 

Mr. and Mrs. Allen e. Kibat 

Dr. and Mrs. John J. Kishel 

Mrs. Laura S. Kopp 

Korea economic Institute 

Mr. Glen Kruglak 

Landmark Partners Inc. 

Mr. and Mrs. Daniel M. Lebey 

Mr. and Mrs. Thomas f. Lechner 

Ms. Shinwha Lee 

Mr. and Mrs. Marc Levy 

Ms. elizabeth O. Liboa-farrow 

Mr. and Mrs. Gregory W. Lindenstruth 

Mr. robert Low, Jr. 

Ms. Patricia e. Maddalone 

Peri N. Mahaley, esq. 

Manekin, LLC 

Mr. Patrick A. Mannion 

Ms. Ahriq Marshall 

Dr. and Mrs. John L. Marshall 

Ms. Loretta M. Marshall 

Mr. robert W. Mayer 

Mr. Barry McDowell 

H. Thomas McDuffie and Barbara Schaefer 

McDuffie 

Ms. Lynn McKinley-Grant 

Mr. and Mrs. David Jan Mitchell 

Mr. and Mrs. Toby Moffett 

Ms. Kristen Morris 

Mr. and Mrs. robert S. Mueller, III 

Nardi Construction Inc. 

Mr. Marcus Noland 

Mrs. elizabeth Orr 

The PAZ fund 

Mrs. Janet K. Phillips 

Mrs. Carole J. Poling 

Ms. Vivianne Pommier 

Mr. Sanjiv Prakash 

Mr. robert H. Pry 

Mr. and Mrs. Stephen Pryor 

Mr. Domenick ricci 

Dr. Maryse robert 

Mr. and Mrs. Kenneth A. Samet 

Mrs. Patricia S. Scanlon 

Drs. Julian Moiseiwitsch and françoise 

Sellier-Moiseiwitsch 

Mr. and Mrs. richard L. Shafer 

ShawnCoulson, LLP 

Mr. Daniel f. Sheehan 

Sherwin-Williams/Duron 

Ms. Laurent P. Sirois 

Mr. David Sittler 

Dr. Genevieve Brunet Smith 

Mr. and Mrs. Howard W. Solomon 

Ms. Diana Sullivan 

Mr. Daniel M. Threlkel 

The M.W. and frances J. Tilghman fund 

Ms. Karla Underwood 

Mr. Bailey G. Walsh 

Mr. and Mrs. Matthew D. Ward 

Wiley rein, LLP 

Mr. David Wine 

Mr. and Mrs. Thomas W. Wood 

elizabeth and Kevin Wrege 

Mr. and Mrs. reynolds Young 

27

28 


the prince charitabLe trusts 

the prince charitable trusts is a long-standing philanthropic partner of 

georgetown university, and a member of the prestigious 1789 society. since 

1998, their focus has been on creating programming to enhance staff morale 

at lombardi and georgetown university hospital. With initial grants of 

$50,000 to the palliative care and the arts and humanities programs, and a 

subsequent commitment of $500,000, the prince charitable trusts is providing 

for the highest possible quality of life for patients and staff at lombardi 

and the hospital. 

according to nancy morgan, ma-tla, director of arts and humanities, 

“the prince trustees embrace a unique vision regarding the support of hospital 

staff as essential to optimal patient care. With their understanding and 

support, we have engaged our nurses, medical students, chaplains and other 

medical caregivers in arts activities that renew energy, instill a spirit of collaboration, 

and provide emotional expression—all essential to good health and 

good medical practice.” 

mr. and mrs. prince were inspired to provide support for these programs 

through the prince charitable trusts because, “the contributions of the staff 

are so invaluable and so multi-faceted that we wanted to find a way of giving 

back to them that enhances their health and well-being in equal measure. We 

believe this program honors our intentions.” 

A program supported by a grant from Prince helps staff members relieve stress through drumming. � 

Gifts in kind 

$10,000–$50,000 

American Airlines 

Sarah Boyer Jenkins & Associates 

$1,000–$9,999 

Bellagio resort 

Bermingham Photography 

The Breakers - Palm Beach 

Brown Jordan/elton Associates Inc. 

Cafe Oggi 

Carole roberts enterprises 

Century Designer Showroom 

The Clifton Inn 

Continental Jewelers 

Crate & Barrel 

Creative Parties 

Debevec Interiors Incorporated 

Duralee fabrics, Ltd. 

evelyn Brooks Designs 

executive 411 

f. Schumacher & Co. 

fitness Together, Alexandria 

freed Photography Inc. 

The Greenbrier 

Gregory fine Portraits 

The Hay Adams Hotel 

Hela Spa 

The Henley Park Hotel 

Hilton Hawaiian Village 

John Hancock financial Services 

Key Title 

Jill Kirkpatrick and Tony Connor 

Justine Sancho Interior Design 

Klipsch Audio Technologies 

Dr. and Mrs. Stuart Kushel 

La Samanna 

Lancôme 

Lloyd-Meurer Portrait Studio of 

Potomac Village 

Dr. and Mrs. Csaba L. Magassy 

Mandalay Bay resort & Casino 

Marriott Wardman Park Hotel 

Michael - Cleary, LLC 

MLS Gallery 

Mohegan Sun 

Nina McLemore 

Nissan Pavilion 

Norfolk Southern Corporation 

P & C Art 

The Hon. Bob Packwood 

Picture frame factory 

Ms. eliana Porath 

random Harvest 

The ritz-Carlton, Cancun 

The ritz-Carlton, Amelia Island 

The ritz-Carlton, Bachelor Gulch 

The ritz-Carlton, Georgetown 

ritz-Carlton, Laguna Niguel 

ritz-Carlton Lake Las Vegas 

The ritz-Carlton Leadership Center 

The ritz-Carlton New York, Battery 

Park 

The ritz-Carlton Orlando, Grande 

Lakes 

ritz-Carlton, Powerscourt, County 

Wicklow 

The ritz-Carlton San Juan Hotel, Spa 

and Casino 

rMA Worldwide Chauffered 

Transportation 

Mr. Joseph e. robert, Jr. 

rSVP Catering 

Sarah Boyer Jenkins & Associates 

Albert Shvilly Studio 

Sofitel Lafayette Square 

Sport & Health Clubs 

State Plaza 

Stroheim & roman 

Tiny Jewel Box 

Towne Silver & Goldsmith 

Versace 

Vespa Washington 

Washington Institute for Dentistry & 

Toxicology

from the director - Georgetown University

Create successful ePaper yourself

Delete template?

Save as template?